These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9510986)

  • 1. Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulphoxide metabolites in rats.
    Redondo PA; Alvarez AI; García JL; Villaverde C; Prieto JG
    Biopharm Drug Dispos; 1998 Jan; 19(1):65-70. PubMed ID: 9510986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics of albendazole and metabolites in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and ex vivo uptake of albendazole and its sulphoxide metabolite by cestode parasites: relationship with their kinetic behaviour in sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    J Vet Pharmacol Ther; 1999 Apr; 22(2):77-86. PubMed ID: 10372592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified plasma and abomasal disposition of albendazole in nematode-infected sheep.
    Alvarez LI; Sánchez SF; Lanusse CE
    Vet Parasitol; 1997 May; 69(3-4):241-53. PubMed ID: 9195734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects of the pharmacokinetics of albendazole sulphoxide in sheep.
    Goudah A
    Vet Res Commun; 2003 Oct; 27(7):555-66. PubMed ID: 14609267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of amphiphilic surfactant agents on the gastrointestinal absorption of albendazole in cattle.
    Virkel G; Imperiale F; Lifschitz A; Pis A; Alvarez A; Merino G; Prieto J; Lanusse C
    Biopharm Drug Dispos; 2003 Apr; 24(3):95-103. PubMed ID: 12673667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.
    Gokbulut C; Cirak VY; Senlik B
    Vet Res Commun; 2006 Oct; 30(7):791-805. PubMed ID: 17004041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tissue residues of hydrochloric acid albendazole sulfoxide and its metabolites in crucian carp (Carassius auratus) after oral administration.
    Li Z; Chen C; Ai D; Wang C; Li J; Qi Y; Yi W; Shen H; Cao J
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):197-204. PubMed ID: 22227164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves.
    Sánchez SF; Alvarez LI; Lanusse CE
    J Vet Pharmacol Ther; 1997 Feb; 20(1):38-47. PubMed ID: 9049948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs.
    Dib A; Palma S; Suárez G; Farías C; Cabrera P; Castro S; Allemandi D; Moreno L; Lanusse C; Sánchez Bruni S
    J Vet Pharmacol Ther; 2011 Apr; 34(2):136-41. PubMed ID: 21395604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: developmental toxicity.
    Cristòfol C; Navarro M; Franquelo C; Valladares JE; Carretero A; Ruberte J; Arboix M
    Toxicol Appl Pharmacol; 1997 May; 144(1):56-61. PubMed ID: 9169069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced plasma availability of the metabolites of albendazole in fasted adult sheep.
    Lifschitz A; Virkel G; Mastromarino M; Lanusse C
    Vet Res Commun; 1997 Apr; 21(3):201-11. PubMed ID: 9090047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of albendazole and its main metabolites in plasma.
    Garcia JJ; Bolás-Fernández F; Torrado JJ
    J Chromatogr B Biomed Sci Appl; 1999 Feb; 723(1-2):265-71. PubMed ID: 10080654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime.
    López-García ML; Torrado S; Torrado S; Martínez AR; Bolás F
    Vet Parasitol; 1998 Feb; 75(2-3):209-19. PubMed ID: 9637222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced plasma and target tissue availabilities of albendazole and albendazole sulphoxide in fasted calves: evaluation of different fasting intervals.
    Sánchez S; Alvarez L; Sallovitz J; Lanusse C
    J Vet Pharmacol Ther; 2000 Aug; 23(4):193-201. PubMed ID: 11126322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent systemic exposure of albendazole metabolites in lambs.
    Alvarez L; Suárez G; Ceballos L; Moreno L; Lanusse C
    J Vet Pharmacol Ther; 2012 Aug; 35(4):365-72. PubMed ID: 21819410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.